|
Alli Brand of Orlistat
Orlistat - Alli - The lower dose version available over the counter
While Orlistat has had a major impact upon the treatment of obesity, there are still many issues stopping vast numbers of suffers from actually becoming actively involved in the treatment. As the number of suffers continues to grow, especially within the younger generation, there is a real concern that the situation is getting out of control. There are even moves within places such as the UK to actively prosecute parents who let their children’s weight spiral out of control - with the first active “neglect” case already processed through the UK courts.
The fact that the authorities are taking the issue so serious has prompted many to review their particular situations, both personally and for their children. However, there are still social acceptability issues with many suffers unable or unwilling to recognise their difficulties, and some adamant that they do not want to visit a doctor.
To many it is then a god send that a new variation of Orlistat has been introduced in the form of Alli, a treatment which is now available over the counter in many countries around the world. Early indications are that the treatment is “flying off the shelves” with record sales over taking any other obesity treatment before. Due to the strict and thorough testing of the treatment, the US Food and Drugs Administration (FDA) have actually, for the first time ever, approved an obesity drug for sale “over the counter”, i.e. without prescription.
This has opened up a whole new market for the treatment, taking in the many thousands of people who were either unable to or refused to take medical advice. The fact that the treatment is now available over the counter means that it is readily available and without the often uncomfortable situation of discussing personal issues with a doctor - this to many has been a major obstacle. It also offers many the opportunity for the public to consider purchasing the treatment prior to any weight issues growing out of control - it is this aspect which is perhaps as important as the treatment of the clinically obese suffers which receive such a bad press throughout the world.
While the dosage of Alli has been reduced to 60g for over the counter sales, rather than the 120g enjoyed by Orlistat users, the treatment still has the potential to make a huge difference. Unlike so many other treatments before (only available on prescription), the fact that Alli works via a physical method rather than trying to influence thought and brain patterns (or even surgery) is also an added bonus. Alli works by restricting the body’s production of enzymes in the intestine, which allow fatty food content to be converted into fatty acid and absorbed into the body. By reducing the production of these enzymes there is an immediate 30% reduction in the absorption of fat into the body - having an immediate impact upon weight loss.
While there are a number of side effects, in the shape of irregular bowel movements, oily and loose stools as well as increased flatulence, because the treatment is at a lesser dosage than Orlistat the side effects are greatly reduced. However, these side effects can be easily controlled by a reduction in the intake of fatty food content, increased exercise and a general change in dietary habits. The massive impact that Alli will have on obesity sufferers can be even greater if used in conjunction with a generally healthier lifestyle - improved dietary habits and even just increased light exercise. It is essential that Alli is used as the catalysts for a new lifestyle, as once the user stops taking the treatment there is every chance of regaining the weight unless more care is taken in the future.
While much has been made of the first hand weight loss, and the immediate impact which Alli has on the body’s intake of fatty acid, few have considered the positive mental impact. Many reports in the past have shown a direct link between obesity, low self esteem, depression and anxiety. These are conditions which have a major impact on people around the world, with millions of working days lost through depression, and an ever increasing burden on the medical industry. For many years now doctors have been reporting a major increase in stress and depression related illnesses, with many patients waiting years for appointments with therapists.
While Alli is predominately a weight loss treatment, it really has the potential to lift the depressive cycle which many millions of people are currently suffering. There are direct links between weight loss and an increase in self esteem, leading to many sufferers empowering their own lives and going on to successful careers, improved family lives and a general all round feel good factor. Perhaps this is also one of the reasons why the FDA have been so keen to issue their first approval for an over the counter obesity treatment - the impact of which is set to grow and grow.
There is no doubt that Alli has the potential to make a major difference to the lives of many around the world, both young and old, it also has the potential to lift what can often be a very heavy cloud of depression for many stuck in a vicious circle of comfort eating and depression. While new and innovative drugs such as Orlistat (in this case Alli) can take many years to appear on the shelves, the fact that the world renowned and heavy weight authority of the FDA is behind the treatment has made a massive difference.
Many countries with close trading links to the US have their own regulatory authorities, although they have taken the FDA research and approval as a major step towards acceptance in their own country. This has resulted in the traditional time scale for worldwide approval being greatly reduced, to the benefit of the millions of sufferers who have been crying out for such a treatment for years. Prominent market experts are forecasting that Alli will be one of the most successful treatments of all time, a view which seems to be backed up by initial sales reports.
|
Linear Mode
